AstraZeneca may conduct another study to clear up confusion about results from a recent trial of its candidate SARS-CoV-2 vaccine, Bloomberg reports.
AstraZeneca may conduct another study to clear up confusion about results from a recent trial of its candidate SARS-CoV-2 vaccine, Bloomberg reports.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.